
US researchers have developed a DNA test that can accurately identify 18 early-stage cancers across all major human organs. This test, which can analyze proteins in the blood, can help detect these cancers at the earliest stages of development. The test, which uses genetic testing, is expected to be a game-changer in cancer treatment and patient survival rates. The test's accuracy and specificity outperform previous methods, paving the way for a multi-cancer screening test for early detection of 18 solid tumors.
Like
Save
Share